RxDoctor Payments Data

Sequita Richardson, MD

Family Medicine · Raytown, MONPI 1356312458

Payments from drug & device makers

$3,373in general payments, 2019–2025

Across 50 payments — averaging $67.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Novo Nordisk$370
  • Teva Pharmaceuticals USA, Inc.$349
  • Amarin Pharma, Inc.$245
  • GSK$202
  • Medtronic$149
  • plus $677 from 11 others

What the payments were for

  • Food & beverage$3,373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,373 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$26,123
Medicare patients
53
Services billed
358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$124,008
EliquisApixaban57$73,383
JardianceEmpagliflozin56$65,246
LinzessLinaclotide31$39,133
TrulicityDulaglutide17$33,425
MounjaroTirzepatide23$32,304
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$32,004
MyrbetriqMirabegron27$30,429
JanuviaSitagliptin Phosphate16$24,325
FarxigaDapagliflozin Propanediol16$16,944
Spiriva HandihalerTiotropium Bromide21$14,846
Tresiba Flextouch U-100Insulin Degludec16$10,577
SymbicortBudesonide/Formoterol Fumarate16$7,030
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$4,939
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$4,374

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$370$124,00881 claims
Lilly USA, LLCTrulicity, Mounjaro$21$65,72940 claims
GSKTrelegy Ellipta, Arexvy$202$35,71049 claims
Astellas Pharma US IncMyrbetriq$112$30,42927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Raytown

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →